Literature DB >> 35368360

Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: CON.

Jonathan Barratt1.   

Abstract

Entities:  

Keywords:  IgA glomerulonephritis; IgA nephropathy; adrenal cortex hormones; glomerular and tubulointerstitial diseases; steroids

Mesh：

Substances：

Year:  2021        PMID： 35368360      PMCID： PMC8786089          DOI： 10.34067/KID.0007672020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  10 in total

1.  Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.

Authors:  Jin-Hua Hou; Wei-Bo Le; Nan Chen; Wei-Ming Wang; Zhang-Suo Liu; Dong Liu; Jiang-Hua Chen; Jiong Tian; Ping Fu; Zhang-Xue Hu; Cai-Hong Zeng; Shao-Shan Liang; Min-Lin Zhou; Hai-Tao Zhang; Zhi-Hong Liu
Journal:  Am J Kidney Dis       Date:  2017-02-16       Impact factor: 8.860

2.  Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

Authors:  Francis W Ballardie; Ian S D Roberts
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Corticosteroids in IgA nephropathy: a randomised controlled trial.

Authors:  C Pozzi; P G Bolasco; G B Fogazzi; S Andrulli; P Altieri; C Ponticelli; F Locatelli
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

4.  After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

Authors:  Thomas Rauen; Stephanie Wied; Christina Fitzner; Frank Eitner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Klemens Budde; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  Kidney Int       Date:  2020-05-22       Impact factor: 10.612

5.  Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.

Authors:  Thomas Rauen; Christina Fitzner; Frank Eitner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 10.121

6.  Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.

Authors:  C Manno; L Gesualdo; C D'Altri; M Rossini; G Grandaliano; F P Schena
Journal:  J Nephrol       Date:  2001 Jul-Aug       Impact factor: 3.902

7.  Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.

Authors:  Jicheng Lv; Hong Zhang; Yuqing Chen; Guangtao Li; Lei Jiang; Ajay K Singh; Haiyan Wang
Journal:  Am J Kidney Dis       Date:  2008-10-19       Impact factor: 8.860

8.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

9.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

10.  Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Jürgen Floege; Sean J Barbour; Daniel C Cattran; Jonathan J Hogan; Patrick H Nachman; Sydney C W Tang; Jack F M Wetzels; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Brad H Rovin
Journal:  Kidney Int       Date:  2019-02       Impact factor: 10.612
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.